Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
209 Leser
Artikel bewerten:
(1)

Cancer Registry Software Market size worth $ 123.67 Million, Globally, by 2028 at 11.4% CAGR: Verified Market Research

Finanznachrichten News

Increasing prevalence of cancer, rising number of cancer patients, efforts to reduce healthcare cost, post market surveillance to analyze cancer trends and other health issues are some of the factors to boost Cancer Registry Software Market.

JERSEY CITY, N.J., May 16, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Cancer Registry Software Market" By Type (Integrated Software, Standalone Software), By Database Type (Public Databases, Commercial Databases), By Functionality (Product Outcome Evaluation, Patient Care Management), By End User (Research Centre, Private Payers), and By Geography. According to Verified Market Research, the Global Cancer Registry Software Market size was valued at USD 52.12 Million in 2020 and is projected to reach USD 123.67 Million by 2028, growing at a CAGR of 11.4% from 2021 to 2028.

Verified Market Research Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=7549

Browse in-depth TOC on "Cancer Registry Software Market"

202 - Pages
126 - Tables
37 - Figures

Global Cancer Registry Software Market Overview

With the rising incidence of cancer and favorable government, the market for cancer registry software is growing. Other factors, such as the rising use of cancer patient registry data for post-marketing surveillance and the increasing number of managed care organizations, are contributing to the market's growth. Numerous government organizations take the initiative and offer assistance to build cancer registries to reduce the burden of cancer. With the increasing demands for population health management and health information exchange, governments worldwide are introducing initiatives to computerize and integrate healthcare systems, like the creation of computerized disease registries.

Moreover, the increasing adoption for ensuring transparency across departments and the versatility to access data at any location and at any time has increased the demand for creative technologies, boosting market growth. Furthermore, Shifting organizational preferences away from traditional management methods, growing demands for automated systems and solutions, linking remote patients, and the increasing popularity of telemedicine are driving the market growth. Cancer patient registries involve health information data that include a wide range of demographic information and personal characteristics including socioeconomic and marital status, official education level, mental delays, cognitive capacities, emotional maturity, gender, age, and race.

Key Developments

  • In November 2018, Onco enhanced OncoLog Version 4.4.0 the most recent NAACCR, AJCC, CoC, and SEER requirements.

Key Players

The major players in the market are Onco, Inc., C/Net Solutions, Elekta AB (PUB), Rocky Mountain Cancer Data Systems, Electronic Registry Systems, Inc. and Mckesson Corporation.

Verified Market Research has segmented the Global Cancer Registry Software Market On the basis of Type, Database Type, Functionality, End User, and Geography.

  • Cancer Registry Software Market, By Type
    • Integrated Software
    • Standalone Software
  • Cancer Registry Software Market, By Database Type
    • Public Databases
    • Commercial Databases
  • Cancer Registry Software Market, By Functionality
    • Medical Research & Clinical Studies
    • Cancer Reporting to Meet State and Federal Regulations
    • Product Outcome Evaluation
    • Patient Care Management
  • Cancer Registry Software Market, By End User
    • Government Organizations & Third-Party Administrators
    • Hospitals & Medical Practices
    • Private Payers
    • Pharmaceutical, Biotechnology, and Medical Device Companies
    • Research Centre
  • Cancer Registry Software Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Blockchain Technology In Healthcare Market By Type (Public and Private), By End-Use (Hospital, Insurance Providers, Drug and Medical Device Manufacturers), By Application (Claims Adjudication & Billing, Clinical Data Exchange & Interoperability), By Geography, Forecast, 2021-2028

Medical Terminology Software Market By Application (Data Aggregation, Decision Support, Clinical Trials), By End User (Healthcare Providers, Healthcare Payers, Healthcare IT Vendors), By Geography, Forecast, 2021-2028

Neuromorphic Computing Market By Deployment (Edge Computing & Cloud Computing), By Offering (Hardware & Software), By Application (Image Processing, Signal Processing, Data Processing, Object Detection), By Vertical (Automotives, Consumer Electronics, Aerospace, Military and Defense, IT and Telecommunication), By Geography, Forecast, 2021-2028

Standalone Cancer Registry Software Market By Product (Public Database, Commercial Database), By Application (Hospitals, Healthcare Providers, Research Centers), By Geography, Forecast, 2021-2028

Top 10 Patient Registry Software fastracking patient care activities using medical data

Visualize Cancer Registry Software Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.